From 2023 to 2024, coverage with one or more doses of the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) and the quadrivalent meningococcal conjugate vaccine ...

Human papillomavirus (HPV) vaccine coverage among teens remained stalled for a second consecutive year since the pandemic, CDC data showed. In 2023, 76.8% of adolescents ages 13 to 17 years had ...

Only 61 percent of U.S. 13-to-17-year-olds have been fully vaccinated against the human papillomavirus (HPV), according to research published last month by the Centers for Disease Control and ...

School-entry immunization requirements are a valuable strategy to reduce the spread of vaccine-preventable diseases. This research examined the temporal relationship between recommendations issued by ...

For the third consecutive year, HPV vaccination coverage remained stable, with 78.2 and 62.9% of adolescents having received 1 or more doses and being up to date with the HPV vaccination series, ...

Only 61% of U.S. 13-to-17-year-olds have been fully vaccinated against the human papillomavirus, according to research published last month by the Centers for Disease Control and Prevention. The ...